The concept comes from pharmacokinetic thinking
Always check the label on your specific vial
The study employed a dose-escalation protocol to mitigate gastrointestinal side effects: Weeks 04: 2 mg once weekly (for groups escalating to 4 mg, 8 mg, or 12 mg) Weeks 58: 4 mg once weekly (for groups escalating to 8 mg or 12 mg) Weeks 912: 8 mg once weekly (for the 12 mg group only) Weeks 1348: Maintenance dose (4 mg, 8 mg, or 12 mg depending on group assignment) This gradual escalation reduced the incidence and severity of nausea compared to immediate initiation at higher doses
doi: 10.2105/AJPH.2013.301597, 11 BoyeK.RossM.ModyR.KonigM.GelhornH
Some scientists hypothesize it could: Work synergistically with GLP-1 and GLP-2 Have unique metabolic or gut health effects Play a role in signaling pathways we dont yet understand For now, GLP-3 remains largely in the realm of basic research rather than practical therapeutic application
Your GP, health visitor or midwife can advise on local availability
